446 related articles for article (PubMed ID: 23845884)
41. DEVELOPMENT AND VALIDATION OF THE STABILITY-INDICATING LC-UV METHOD FOR DETERMINATION OF CEFOZOPRAN HYDROCHLORIDE.
Zalewski P; Garbacki P; Cielecka-Piontek J; Bednarek-Rajewska K; Krause A
Acta Pol Pharm; 2015; 72(3):423-7. PubMed ID: 26642650
[TBL] [Abstract][Full Text] [Related]
42. Method development and validation for the determination of indiquinoline tartrate, a novel kappa opioid agonist, and its related substances by high-performance liquid chromatography.
Sun C; Shen Y; Sun D; Hang T; Tu J
J Chromatogr Sci; 2012 Apr; 50(4):343-8. PubMed ID: 22407345
[TBL] [Abstract][Full Text] [Related]
43. A validated stability indicating ion-pair RP-LC method for zoledronic acid.
Rao BM; Srinivasu MK; Rani ChP; kumar SS; Kumar PR; Chandrasekhar KB; Veerender M
J Pharm Biomed Anal; 2005 Sep; 39(3-4):781-90. PubMed ID: 15922532
[TBL] [Abstract][Full Text] [Related]
44. Stability-indicating UPLC method for determination of Imatinib Mesylate and their degradation products in active pharmaceutical ingredient and pharmaceutical dosage forms.
Nageswari A; Reddy KV; Mukkanti K
J Pharm Biomed Anal; 2012 Jul; 66():109-15. PubMed ID: 22502910
[TBL] [Abstract][Full Text] [Related]
45. A stability-indicating ultra-performance liquid chromatographic method for estimation of related substances and degradants in paliperidone active pharmaceutical ingredient and its pharmaceutical dosage forms.
Bindu KH; Reddy IU; Anjaneyulu Y; Suryanarayana MV
J Chromatogr Sci; 2012 Apr; 50(4):368-72. PubMed ID: 22407348
[TBL] [Abstract][Full Text] [Related]
46. Development and validation of stability-indicating assay method by UPLC for a fixed dose combination of atorvastatin and ezetimibe.
Goel A; Baboota S; Sahni JK; Srinivas KS; Gupta RS; Gupta A; Semwal VP; Ali J
J Chromatogr Sci; 2013 Mar; 51(3):222-8. PubMed ID: 22865836
[TBL] [Abstract][Full Text] [Related]
47. Stability-indicating LC-UV method for the determination of eszopiclone and degradation impurities in tablet dosage form.
Shaikh K; Patil A; Gite S
J Chromatogr Sci; 2014 Apr; 52(4):293-7. PubMed ID: 23552846
[TBL] [Abstract][Full Text] [Related]
48. Stability-indicating RP-HPLC method for the simultaneous determination of escitalopram oxalate and clonazepam.
Kakde RB; Satone DD; Gadapayale KK; Kakde MG
J Chromatogr Sci; 2013 Jul; 51(6):490-5. PubMed ID: 23135233
[TBL] [Abstract][Full Text] [Related]
49. A Stability-Indicating UPLC Method for the Determination of Potential Impurities and Its Mass by a New QDa Mass Detector in Daclatasvir Drug Used to Treat Hepatitis C Infection.
Jagadabi V; Nagendra Kumar PV; Mahesh K; Pamidi S; Ramaprasad LA; Nagaraju D
J Chromatogr Sci; 2019 Jan; 57(1):44-53. PubMed ID: 30169761
[TBL] [Abstract][Full Text] [Related]
50. Development of a stability- indicating HPLC method for simultaneous determination of ten related substances in vonoprazan fumarate drug substance.
Luo Z; Liu A; Liu Y; Wang G; Chen X; Wang H; Li M; Zhang H; Qiu Y; Zhai H
J Pharm Biomed Anal; 2018 Feb; 149():133-142. PubMed ID: 29112902
[TBL] [Abstract][Full Text] [Related]
51. Simultaneous Determination of Impurities of Atazanavir and Ritonavir in Tablet Dosage Form by Using Reversed-Phase Ultra Performance Liquid Chromatographic Method.
Mantripragada MKVVN; Rao SV; Nutulapati VVS; Mantena BPV
J Chromatogr Sci; 2018 Mar; 56(3):270-284. PubMed ID: 29300835
[TBL] [Abstract][Full Text] [Related]
52. The ultra-performance liquid chromatography determination of domperidone and its process-related impurities.
Curtin Whelan L; Geary M; Wharton M; Sweetman P
J Chromatogr Sci; 2015 Feb; 53(2):226-32. PubMed ID: 24904093
[TBL] [Abstract][Full Text] [Related]
53. Development and validation of a stability-indicating RP-HPLC assay method and stress degradation studies on dapiprazole.
Ramesh T; Rao PN
J Chromatogr Sci; 2013 Oct; 51(9):856-60. PubMed ID: 23169931
[TBL] [Abstract][Full Text] [Related]
54. Preparation and characterization of two new forced degradation products of letrozole and development of a stability-indicating RP-LC method for its determination.
Elkady EF; Fouad MA
Pak J Pharm Sci; 2015 Nov; 28(6):2041-51. PubMed ID: 26639498
[TBL] [Abstract][Full Text] [Related]
55. Selective determination of diclazuril in the presence of its degradation products.
Rezk MR
J Chromatogr Sci; 2015 Feb; 53(2):302-6. PubMed ID: 25002681
[TBL] [Abstract][Full Text] [Related]
56. Liquid chromatographic determination of amikacin sulphate after pre-column derivatization.
Korany MA; Haggag RS; Ragab MA; Elmallah OA
J Chromatogr Sci; 2014 Sep; 52(8):837-47. PubMed ID: 24006430
[TBL] [Abstract][Full Text] [Related]
57. LC-MS/MS characterization of forced degradation products of zofenopril.
Ramesh T; Nageswara Rao P; Nageswara Rao R
J Pharm Biomed Anal; 2014 Jan; 88():609-16. PubMed ID: 24211724
[TBL] [Abstract][Full Text] [Related]
58. Development and validation of a stability-indicating HPLC method for determination of voriconazole and its related substances.
Gu P; Li Y
J Chromatogr Sci; 2009 Aug; 47(7):594-8. PubMed ID: 19772734
[TBL] [Abstract][Full Text] [Related]
59. Development and validation of a stability-indicating RP-LC method for famciclovir.
Raman NV; Harikrishna KA; Prasad AV; Ratnakar Reddy K; Ramakrishna K
J Pharm Biomed Anal; 2009 Dec; 50(5):797-802. PubMed ID: 19632799
[TBL] [Abstract][Full Text] [Related]
60. Development and validation of a reversed-phase ultra-performance liquid chromatographic method for assay of lacidipine and related substances.
Mohan A; Patel HB; Saravanan D
J AOAC Int; 2011; 94(6):1800-6. PubMed ID: 22320087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
